nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—liver cancer	0.355	0.727	CbGaD
Nateglinide—ALB—liver cancer	0.133	0.273	CbGaD
Nateglinide—UGT1A9—Sorafenib—liver cancer	0.116	0.301	CbGbCtD
Nateglinide—ABCC4—Sorafenib—liver cancer	0.0966	0.252	CbGbCtD
Nateglinide—CYP3A7—Sorafenib—liver cancer	0.0384	0.1	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0384	0.1	CbGbCtD
Nateglinide—CYP3A5—Sorafenib—liver cancer	0.0288	0.0751	CbGbCtD
Nateglinide—CYP2C9—Sorafenib—liver cancer	0.0193	0.0504	CbGbCtD
Nateglinide—CYP2D6—Sorafenib—liver cancer	0.0177	0.046	CbGbCtD
Nateglinide—CYP3A4—Sorafenib—liver cancer	0.0112	0.0293	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—liver cancer	0.0107	0.0279	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—liver cancer	0.00681	0.0178	CbGbCtD
Nateglinide—L-Phenylalanine—TAT—liver cancer	0.00205	0.625	CrCbGaD
Nateglinide—ORM1—bile—liver cancer	0.00172	0.368	CbGeAlD
Nateglinide—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.000895	0.0876	CcSEcCtD
Nateglinide—Mitiglinide—PPARG—liver cancer	0.000736	0.224	CrCbGaD
Nateglinide—Bortezomib—CYP1A1—liver cancer	0.000493	0.15	CrCbGaD
Nateglinide—ORM1—gall bladder—liver cancer	0.000478	0.102	CbGeAlD
Nateglinide—ALB—gall bladder—liver cancer	0.000419	0.0895	CbGeAlD
Nateglinide—Neuropathy peripheral—Sorafenib—liver cancer	0.000289	0.0282	CcSEcCtD
Nateglinide—Jaundice—Sorafenib—liver cancer	0.000287	0.0281	CcSEcCtD
Nateglinide—PPARG—embryo—liver cancer	0.000283	0.0605	CbGeAlD
Nateglinide—Hepatobiliary disease—Sorafenib—liver cancer	0.000279	0.0273	CcSEcCtD
Nateglinide—UGT1A9—liver—liver cancer	0.000266	0.0569	CbGeAlD
Nateglinide—Erythema multiforme—Sorafenib—liver cancer	0.00025	0.0245	CcSEcCtD
Nateglinide—Immune system disorder—Sorafenib—liver cancer	0.000239	0.0234	CcSEcCtD
Nateglinide—Malnutrition—Sorafenib—liver cancer	0.00023	0.0225	CcSEcCtD
Nateglinide—CYP3A7—liver—liver cancer	0.000221	0.0473	CbGeAlD
Nateglinide—Arthropathy—Epirubicin—liver cancer	0.000214	0.0209	CcSEcCtD
Nateglinide—Cough—Sorafenib—liver cancer	0.000201	0.0197	CcSEcCtD
Nateglinide—Arthropathy—Doxorubicin—liver cancer	0.000198	0.0194	CcSEcCtD
Nateglinide—CYP3A7-CYP3A51P—liver—liver cancer	0.000188	0.0402	CbGeAlD
Nateglinide—Dyspepsia—Sorafenib—liver cancer	0.000165	0.0162	CcSEcCtD
Nateglinide—SLC15A1—liver—liver cancer	0.000164	0.035	CbGeAlD
Nateglinide—Gastrointestinal disorder—Sorafenib—liver cancer	0.000162	0.0159	CcSEcCtD
Nateglinide—Fatigue—Sorafenib—liver cancer	0.000162	0.0158	CcSEcCtD
Nateglinide—SLC16A1—liver—liver cancer	0.000156	0.0333	CbGeAlD
Nateglinide—Gastrointestinal pain—Sorafenib—liver cancer	0.000154	0.015	CcSEcCtD
Nateglinide—Increased appetite—Epirubicin—liver cancer	0.00015	0.0147	CcSEcCtD
Nateglinide—Urticaria—Sorafenib—liver cancer	0.000149	0.0146	CcSEcCtD
Nateglinide—Abdominal pain—Sorafenib—liver cancer	0.000148	0.0145	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—liver cancer	0.000145	0.0142	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—liver cancer	0.000141	0.0138	CcSEcCtD
Nateglinide—ORM1—liver—liver cancer	0.00014	0.0299	CbGeAlD
Nateglinide—Increased appetite—Doxorubicin—liver cancer	0.000139	0.0136	CcSEcCtD
Nateglinide—Hypersensitivity—Sorafenib—liver cancer	0.000138	0.0135	CcSEcCtD
Nateglinide—Asthenia—Sorafenib—liver cancer	0.000135	0.0132	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—liver cancer	0.000134	0.0131	CcSEcCtD
Nateglinide—Pruritus—Sorafenib—liver cancer	0.000133	0.013	CcSEcCtD
Nateglinide—PPARG—liver—liver cancer	0.000131	0.028	CbGeAlD
Nateglinide—Osteoarthritis—Doxorubicin—liver cancer	0.000131	0.0128	CcSEcCtD
Nateglinide—Diarrhoea—Sorafenib—liver cancer	0.000129	0.0126	CcSEcCtD
Nateglinide—Dizziness—Sorafenib—liver cancer	0.000124	0.0122	CcSEcCtD
Nateglinide—ALB—liver—liver cancer	0.000123	0.0262	CbGeAlD
Nateglinide—Influenza—Epirubicin—liver cancer	0.000122	0.0119	CcSEcCtD
Nateglinide—Vomiting—Sorafenib—liver cancer	0.000119	0.0117	CcSEcCtD
Nateglinide—ABCC4—liver—liver cancer	0.000119	0.0254	CbGeAlD
Nateglinide—Rash—Sorafenib—liver cancer	0.000118	0.0116	CcSEcCtD
Nateglinide—Dermatitis—Sorafenib—liver cancer	0.000118	0.0116	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—liver cancer	0.000117	0.0115	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—liver cancer	0.000113	0.0111	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—liver cancer	0.000113	0.0111	CcSEcCtD
Nateglinide—Nausea—Sorafenib—liver cancer	0.000112	0.0109	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—liver cancer	0.000109	0.0106	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—liver cancer	0.000107	0.0104	CcSEcCtD
Nateglinide—Jaundice—Epirubicin—liver cancer	0.000106	0.0104	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000105	0.0103	CcSEcCtD
Nateglinide—Sweating—Epirubicin—liver cancer	0.000104	0.0102	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—liver cancer	0.000103	0.0101	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—liver cancer	9.87e-05	0.00966	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—liver cancer	9.82e-05	0.00961	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—liver cancer	9.65e-05	0.00945	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—liver cancer	9.63e-05	0.00942	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—liver cancer	9.52e-05	0.00932	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—liver cancer	9.24e-05	0.00904	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—liver cancer	8.91e-05	0.00872	CcSEcCtD
Nateglinide—Immune system disorder—Epirubicin—liver cancer	8.83e-05	0.00864	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—liver cancer	8.55e-05	0.00836	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—liver cancer	8.51e-05	0.00832	CcSEcCtD
Nateglinide—Back pain—Epirubicin—liver cancer	8.23e-05	0.00805	CcSEcCtD
Nateglinide—Immune system disorder—Doxorubicin—liver cancer	8.17e-05	0.00799	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—liver cancer	7.87e-05	0.0077	CcSEcCtD
Nateglinide—CYP3A5—liver—liver cancer	7.79e-05	0.0166	CbGeAlD
Nateglinide—CYP2C9—liver—liver cancer	7.67e-05	0.0164	CbGeAlD
Nateglinide—Back pain—Doxorubicin—liver cancer	7.61e-05	0.00745	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—liver cancer	7.52e-05	0.00736	CcSEcCtD
Nateglinide—Cough—Epirubicin—liver cancer	7.42e-05	0.00726	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—liver cancer	6.95e-05	0.00681	CcSEcCtD
Nateglinide—Cough—Doxorubicin—liver cancer	6.87e-05	0.00672	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—liver cancer	6.71e-05	0.00657	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—liver cancer	6.21e-05	0.00608	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—liver cancer	6.11e-05	0.00598	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—liver cancer	5.99e-05	0.00586	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—liver cancer	5.98e-05	0.00586	CcSEcCtD
Nateglinide—CYP3A4—liver—liver cancer	5.85e-05	0.0125	CbGeAlD
Nateglinide—CYP2D6—liver—liver cancer	5.75e-05	0.0123	CbGeAlD
Nateglinide—Gastrointestinal pain—Epirubicin—liver cancer	5.68e-05	0.00555	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—liver cancer	5.65e-05	0.00553	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—liver cancer	5.55e-05	0.00543	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—liver cancer	5.54e-05	0.00542	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—liver cancer	5.51e-05	0.0054	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—liver cancer	5.49e-05	0.00537	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—liver cancer	5.25e-05	0.00514	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—liver cancer	5.11e-05	0.005	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—liver cancer	5.1e-05	0.00499	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—liver cancer	5.08e-05	0.00497	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—liver cancer	4.98e-05	0.00487	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—liver cancer	4.91e-05	0.00481	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—liver cancer	4.75e-05	0.00465	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—liver cancer	4.73e-05	0.00463	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—liver cancer	4.61e-05	0.00451	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—liver cancer	4.59e-05	0.00449	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—liver cancer	4.54e-05	0.00445	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—liver cancer	4.41e-05	0.00432	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—liver cancer	4.39e-05	0.0043	CcSEcCtD
Nateglinide—Rash—Epirubicin—liver cancer	4.38e-05	0.00428	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—liver cancer	4.37e-05	0.00428	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—liver cancer	4.25e-05	0.00416	CcSEcCtD
Nateglinide—Nausea—Epirubicin—liver cancer	4.12e-05	0.00403	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—liver cancer	4.08e-05	0.004	CcSEcCtD
Nateglinide—Rash—Doxorubicin—liver cancer	4.05e-05	0.00396	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—liver cancer	4.05e-05	0.00396	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—liver cancer	3.82e-05	0.00373	CcSEcCtD
Nateglinide—UGT1A9—Metabolism—HMOX1—liver cancer	1.22e-05	0.00011	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTA1—liver cancer	1.22e-05	0.00011	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NAT2—liver cancer	1.2e-05	0.000109	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CD—liver cancer	1.2e-05	0.000109	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NR1H4—liver cancer	1.19e-05	0.000108	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ALB—liver cancer	1.19e-05	0.000108	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TAT—liver cancer	1.19e-05	0.000107	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.18e-05	0.000107	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYCS—liver cancer	1.18e-05	0.000107	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NR1H4—liver cancer	1.18e-05	0.000107	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK14—liver cancer	1.17e-05	0.000106	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTA3—liver cancer	1.17e-05	0.000106	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—MTHFR—liver cancer	1.17e-05	0.000106	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CD—liver cancer	1.17e-05	0.000106	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	1.16e-05	0.000105	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTA3—liver cancer	1.16e-05	0.000105	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.16e-05	0.000105	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GOT1—liver cancer	1.16e-05	0.000105	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GGT1—liver cancer	1.16e-05	0.000105	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ALDOB—liver cancer	1.15e-05	0.000104	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ALB—liver cancer	1.15e-05	0.000104	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CD—liver cancer	1.15e-05	0.000104	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PPARA—liver cancer	1.15e-05	0.000104	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYCS—liver cancer	1.14e-05	0.000103	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—F2—liver cancer	1.14e-05	0.000103	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTM1—liver cancer	1.13e-05	0.000103	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ALB—liver cancer	1.13e-05	0.000103	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CA—liver cancer	1.12e-05	0.000102	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GOT1—liver cancer	1.12e-05	0.000102	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GGT1—liver cancer	1.12e-05	0.000102	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HPGDS—liver cancer	1.12e-05	0.000101	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CRABP1—liver cancer	1.1e-05	9.97e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	1.1e-05	9.96e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SERPINE1—liver cancer	1.1e-05	9.93e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CG—liver cancer	1.09e-05	9.86e-05	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—liver cancer	1.09e-05	9.84e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP1A1—liver cancer	1.08e-05	9.74e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTA4—liver cancer	1.07e-05	9.68e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—liver cancer	1.07e-05	9.65e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTA4—liver cancer	1.06e-05	9.59e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CB—liver cancer	1.05e-05	9.5e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTA2—liver cancer	1.04e-05	9.43e-05	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—liver cancer	1.04e-05	9.41e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTP1—liver cancer	1.04e-05	9.41e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.04e-05	9.38e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTA2—liver cancer	1.03e-05	9.35e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.03e-05	9.32e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—HMOX1—liver cancer	1.02e-05	9.28e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—IL6—liver cancer	1.02e-05	9.24e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CB—liver cancer	1.02e-05	9.21e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTP1—liver cancer	1.01e-05	9.12e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTA1—liver cancer	1e-05	9.1e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MTHFR—liver cancer	1e-05	9.08e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CB—liver cancer	1e-05	9.08e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTA1—liver cancer	9.96e-06	9.02e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PSMA4—liver cancer	9.95e-06	9.02e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PSMD10—liver cancer	9.95e-06	9.02e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NAT2—liver cancer	9.93e-06	9e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—HMOX1—liver cancer	9.93e-06	8.99e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.91e-06	8.97e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	9.86e-06	8.93e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NAT2—liver cancer	9.85e-06	8.92e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARA—liver cancer	9.84e-06	8.91e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CG—liver cancer	9.81e-06	8.88e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GOT2—liver cancer	9.68e-06	8.77e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HPGDS—liver cancer	9.62e-06	8.71e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CD—liver cancer	9.57e-06	8.66e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.56e-06	8.66e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTM1—liver cancer	9.54e-06	8.65e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALDOB—liver cancer	9.52e-06	8.63e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.47e-06	8.58e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SERPINE1—liver cancer	9.46e-06	8.57e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALDOB—liver cancer	9.44e-06	8.55e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—liver cancer	9.41e-06	8.52e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTM1—liver cancer	9.25e-06	8.38e-05	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—liver cancer	9.18e-06	8.31e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP2E1—liver cancer	9.1e-06	8.25e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CRABP1—liver cancer	9.08e-06	8.23e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP1A1—liver cancer	9.05e-06	8.2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CRABP1—liver cancer	9.01e-06	8.16e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.84e-06	8.01e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP1A1—liver cancer	8.77e-06	7.94e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.71e-06	7.89e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CD—liver cancer	8.62e-06	7.81e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PSMA4—liver cancer	8.57e-06	7.76e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PSMD10—liver cancer	8.57e-06	7.76e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RAF1—liver cancer	8.54e-06	7.74e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYCS—liver cancer	8.52e-06	7.72e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—liver cancer	8.51e-06	7.71e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MTHFR—liver cancer	8.43e-06	7.64e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CG—liver cancer	8.43e-06	7.63e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GGT1—liver cancer	8.36e-06	7.57e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GOT1—liver cancer	8.36e-06	7.57e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GOT2—liver cancer	8.34e-06	7.55e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CB—liver cancer	8.34e-06	7.55e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARA—liver cancer	8.28e-06	7.5e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MTHFR—liver cancer	8.18e-06	7.41e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—liver cancer	8.13e-06	7.37e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.11e-06	7.34e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CPT1B—liver cancer	8.06e-06	7.3e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GLUL—liver cancer	8.06e-06	7.3e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	8.06e-06	7.3e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARA—liver cancer	8.02e-06	7.27e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HPGDS—liver cancer	7.94e-06	7.19e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HPGDS—liver cancer	7.87e-06	7.13e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2E1—liver cancer	7.84e-06	7.1e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.83e-06	7.09e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NR1H4—liver cancer	7.77e-06	7.04e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2—liver cancer	7.66e-06	6.94e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA3—liver cancer	7.64e-06	6.92e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.59e-06	6.88e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CB—liver cancer	7.51e-06	6.81e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—liver cancer	7.51e-06	6.8e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CD—liver cancer	7.41e-06	6.71e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMOX1—liver cancer	7.4e-06	6.71e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	7.39e-06	6.7e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYCS—liver cancer	7.34e-06	6.64e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—liver cancer	7.31e-06	6.62e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.21e-06	6.53e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GGT1—liver cancer	7.2e-06	6.52e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GOT1—liver cancer	7.2e-06	6.52e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.13e-06	6.46e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—liver cancer	7.09e-06	6.42e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PSMA4—liver cancer	7.08e-06	6.41e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PSMD10—liver cancer	7.08e-06	6.41e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.04e-06	6.37e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PSMD10—liver cancer	7.02e-06	6.36e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PSMA4—liver cancer	7.02e-06	6.36e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA4—liver cancer	6.99e-06	6.33e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—liver cancer	6.94e-06	6.29e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—liver cancer	6.9e-06	6.25e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GOT2—liver cancer	6.88e-06	6.24e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—liver cancer	6.87e-06	6.22e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—liver cancer	6.84e-06	6.2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GOT2—liver cancer	6.83e-06	6.18e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA2—liver cancer	6.81e-06	6.17e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—liver cancer	6.63e-06	6.01e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA1—liver cancer	6.57e-06	5.95e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1A1—liver cancer	6.54e-06	5.92e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—liver cancer	6.51e-06	5.89e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NAT2—liver cancer	6.49e-06	5.88e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2E1—liver cancer	6.47e-06	5.86e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—liver cancer	6.47e-06	5.86e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CB—liver cancer	6.46e-06	5.85e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2E1—liver cancer	6.42e-06	5.81e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—liver cancer	6.39e-06	5.79e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—liver cancer	6.38e-06	5.78e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CD—liver cancer	6.23e-06	5.64e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDOB—liver cancer	6.23e-06	5.64e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.21e-06	5.63e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—liver cancer	6.2e-06	5.61e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—liver cancer	6.15e-06	5.57e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—liver cancer	6.11e-06	5.53e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—liver cancer	6.1e-06	5.52e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYCS—liver cancer	6.06e-06	5.49e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CD—liver cancer	6.04e-06	5.47e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYCS—liver cancer	6e-06	5.44e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARA—liver cancer	5.98e-06	5.42e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—liver cancer	5.97e-06	5.41e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—liver cancer	5.96e-06	5.4e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GGT1—liver cancer	5.94e-06	5.38e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GOT1—liver cancer	5.94e-06	5.38e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—liver cancer	5.94e-06	5.38e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CRABP1—liver cancer	5.94e-06	5.38e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GGT1—liver cancer	5.89e-06	5.34e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GOT1—liver cancer	5.89e-06	5.34e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1A1—liver cancer	5.63e-06	5.1e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—liver cancer	5.53e-06	5.01e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CB—liver cancer	5.43e-06	4.92e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—liver cancer	5.34e-06	4.84e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—liver cancer	5.29e-06	4.79e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—liver cancer	5.26e-06	4.77e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CB—liver cancer	5.26e-06	4.77e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—liver cancer	5.25e-06	4.76e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—liver cancer	5.22e-06	4.73e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—liver cancer	5.22e-06	4.73e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HPGDS—liver cancer	5.19e-06	4.7e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARA—liver cancer	5.15e-06	4.67e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—liver cancer	5.12e-06	4.64e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—liver cancer	5.08e-06	4.6e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—liver cancer	5.06e-06	4.59e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—liver cancer	4.99e-06	4.52e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—liver cancer	4.94e-06	4.48e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—liver cancer	4.92e-06	4.45e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—liver cancer	4.91e-06	4.44e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—liver cancer	4.86e-06	4.41e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—liver cancer	4.81e-06	4.36e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—liver cancer	4.7e-06	4.26e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1A1—liver cancer	4.65e-06	4.21e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.63e-06	4.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PSMD10—liver cancer	4.63e-06	4.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PSMA4—liver cancer	4.63e-06	4.19e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1A1—liver cancer	4.61e-06	4.18e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—liver cancer	4.58e-06	4.15e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CD—liver cancer	4.5e-06	4.08e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GOT2—liver cancer	4.5e-06	4.08e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—liver cancer	4.45e-06	4.03e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—liver cancer	4.41e-06	4e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—liver cancer	4.34e-06	3.93e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—liver cancer	4.3e-06	3.89e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—liver cancer	4.26e-06	3.86e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARA—liver cancer	4.25e-06	3.85e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2E1—liver cancer	4.23e-06	3.83e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARA—liver cancer	4.22e-06	3.82e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—liver cancer	4.15e-06	3.76e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYCS—liver cancer	3.96e-06	3.59e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—liver cancer	3.94e-06	3.57e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CB—liver cancer	3.93e-06	3.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GGT1—liver cancer	3.89e-06	3.52e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GOT1—liver cancer	3.89e-06	3.52e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CD—liver cancer	3.88e-06	3.51e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.79e-06	3.43e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—liver cancer	3.74e-06	3.39e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—liver cancer	3.64e-06	3.3e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—liver cancer	3.61e-06	3.27e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—liver cancer	3.52e-06	3.18e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—liver cancer	3.49e-06	3.16e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—liver cancer	3.49e-06	3.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—liver cancer	3.44e-06	3.12e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CB—liver cancer	3.38e-06	3.06e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—liver cancer	3.31e-06	3e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—liver cancer	3.22e-06	2.91e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—liver cancer	3.21e-06	2.91e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—liver cancer	3.21e-06	2.91e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CD—liver cancer	3.2e-06	2.9e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CD—liver cancer	3.17e-06	2.88e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—liver cancer	3.16e-06	2.86e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—liver cancer	3.13e-06	2.84e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1A1—liver cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—liver cancer	2.83e-06	2.57e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CB—liver cancer	2.79e-06	2.53e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARA—liver cancer	2.78e-06	2.52e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CB—liver cancer	2.77e-06	2.51e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—liver cancer	2.7e-06	2.45e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—liver cancer	2.62e-06	2.37e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—liver cancer	2.39e-06	2.17e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—liver cancer	2.38e-06	2.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—liver cancer	2.3e-06	2.08e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CD—liver cancer	2.09e-06	1.9e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—liver cancer	2.07e-06	1.87e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—liver cancer	2.06e-06	1.87e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—liver cancer	1.95e-06	1.77e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CB—liver cancer	1.82e-06	1.65e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—liver cancer	1.7e-06	1.54e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—liver cancer	1.69e-06	1.53e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—liver cancer	1.68e-06	1.52e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—liver cancer	1.39e-06	1.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—liver cancer	1.38e-06	1.25e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—liver cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—liver cancer	9.09e-07	8.23e-06	CbGpPWpGaD
